Aztreonam and ceftazidime-avibactam overlay in extensively drug-resistant bla, bla and bla carbapenemase-producing ​Klebsiella pneumoniae.

Pathology

Department of Microbiology and Infectious Diseases, Concord Hospital, NSW Health Pathology, NSW Health, Sydney, NSW, Australia; School of Medical Sciences, Department of Infection and Immunity, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia. Electronic address:

Published: September 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pathol.2024.07.003DOI Listing

Publication Analysis

Top Keywords

bla bla
8
aztreonam ceftazidime-avibactam
4
ceftazidime-avibactam overlay
4
overlay extensively
4
extensively drug-resistant
4
drug-resistant bla
4
bla carbapenemase-producing ​klebsiella
4
carbapenemase-producing ​klebsiella pneumoniae
4
bla
3
aztreonam
1

Similar Publications

Multiple mechanisms mediate aztreonam-avibactam resistance in Klebsiella pneumoniae: driven by KPC-2 and OmpK36 mutations.

Int J Antimicrob Agents

December 2024

Department of Clinical Laboratory, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang Province, China. Electronic address:

Aztreonam-avibactam (ATM-AVI) is a promising β-lactam/β-lactamase inhibitor combination with an antimicrobial spectrum covering serine carbapenemase- or metallo-β-lactamase-producing Enterobacterales. Although ATM-AVI has not been widely used in clinical practice, resistance to it in Escherichia coli has been widely reported. In this study, we investigated an ATM-AVI-resistant Klebsiella pneumoniae strain, designated as 1705R, derived from K.

View Article and Find Full Text PDF

Background: The study aimed to review the beta-lactamase resistance genes detected in Enterobacterales from humans, animals, and the environment in the United States.

Methods: We conducted a comprehensive search on PubMed, Web of Science, and Google Scholar for articles reporting beta-lactamase genes in the United States from 1981 to 22 April 2022, following the PRISMA protocol. Studies were evaluated based on predefined eligibility criteria, and both qualitative and quantitative analyses were conducted on the selected studies.

View Article and Find Full Text PDF

Background: Klebsiella pneumoniae is a clinically relevant pathogen that has raised considerable public health concerns. This study aims to determine the presence of beta-lactamase genes and perform molecular genotyping of multidrug-resistant (MDR) K. pneumoniae clinical isolates.

View Article and Find Full Text PDF

Silent circulation of plasmid-borne tet(X6) and bla genes in a community-acquired Acinetobacter baumannii strain.

Drug Resist Updat

December 2024

Department of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China; Key Laboratory of Precision Medicine in Diagnosis and Monitoring Research of Zhejiang Province, Hangzhou, China. Electronic address:

To characterize the genomic features of a community-acquired Acinetobacter baumannii strain, co-carrying tet(X6) and bla genes, but was susceptible to tigecycline and carbapenems. The tet(X6) and bla genes were found on a 149,518 bp non-conjugative plasmid. The bla gene was silent, due to the presence of an intact ISAba3-like element upstream, which rendered the strain susceptible to carbapenems.

View Article and Find Full Text PDF

Salmonella is one of the most common foodborne pathogens. Antimicrobial-resistant Salmonella isolates, especially those resistant to colistin, pose a significant threat to public health worldwide. However, data about the prevalence of mcr-positive Salmonella in animals was few and the dissemination of mcr-positive Salmonella from animals to food, especially eggs, has not been fully addressed.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!